The first rural hospital to line up for the life of the new government

Published Date: 08 Mar 2023

Hospitals in New Mexico, Texas and Oklahoma are the first to call for a new rural hospital payment model that shifts services from inpatients to outpatients and emergency patients.

Read Full News

Latest News

Who’s In Charge in the ICU? Families Need to Know

In the Arab region, families often meet intensivists for the first time in a crisis — adding confusion when trust and clear ICU decisions matter most.

JAK Inhibitors: Putting Safety Concerns in Context

After a study revealed higher cancer and other risks with a JAK inhibitor in patients with rheumatoid arthritis, further evidence suggests that the risks may be lower in dermatology.

High-Dose Flu Vaccine Linked to Lower Dementia Risk

Vaccination with a higher dose of the influenza vaccine may reduce the risk of developing dementia among older adults.

New Drugs Are Primary Care Game Changers, but Pricey

Four recent approvals are poised to affect patient care.

Life-Extending Bile Duct Cancer Drug Cleared for NHS Use

NICE has recommended zanidatamab for HER2-positive biliary tract cancer in final draft guidance, offering patients more time and better quality of life.

SARS-CoV-2 Tied to Higher Respiratory Failure Risk Than Flu

Hospitalised adults with SARS-CoV-2, parainfluenza virus, or RSV vs influenza A/B infection experience greater acute respiratory failure, with those with SARS-CoV-2 infection having the greatest risk.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Latest News

In the Arab region, families often meet intensivists for the first time in a crisis — adding confusion when trust and clear ICU decisions matter most.

After a study revealed higher cancer and other risks with a JAK inhibitor in patients with rheumatoid arthritis, further evidence suggests that the risks may be lower in dermatology.

Vaccination with a higher dose of the influenza vaccine may reduce the risk of developing dementia among older adults.

Four recent approvals are poised to affect patient care.

NICE has recommended zanidatamab for HER2-positive biliary tract cancer in final draft guidance, offering patients more time and better quality of life.

Hospitalised adults with SARS-CoV-2, parainfluenza virus, or RSV vs influenza A/B infection experience greater acute respiratory failure, with those with SARS-CoV-2 infection having the greatest risk.

News All Time

Dendritic Cell Strategies May Reduce Cancer Recurrence Risk

Dendritic cells within tumors may enable personalized immunotherapy strategies that reduce the risk for cancer relapses by strengthening immune memory.

Sunflower Seed Sensitization Outpaces True Allergy in Kids

More than 80% of children sensitized to sunflower seeds and advised to avoid them can tolerate the seeds during an oral food challenge.

Adding Steroid Shows No Heart Benefit in Kawasaki Disease

Adding prednisolone to the standard treatment for Kawasaki disease in children does not lower the incidence of coronary artery lesions at 1 month after illness onset, according to a phase 3 trial.

Torque Teno Virus Predicts Malignancy Post-Kidney Transplant

Higher torque teno virus loads during the first year after kidney transplant are associated with an increased risk for malignancies in subsequent years, a prospective study finds.

Allergy Myths Abound on Social Media: Debunk With Care

From probiotics to do-it-yourself IgG test kits, social media is misinforming patients about how to diagnose and manage allergies.

Precision Medicine for Rare Allergies

New biologics, precision diagnostics, and AI are reshaping care for rare allergies — from eosinophilic esophagitis to drug hypersensitivity — moving practice toward personalized treatment.

NICE Backs Belantamab Mafodotin for Relapsed Myeloma

NICE has recommended belantamab mafodotin for relapsed multiple myeloma, with trial data showing remissions of more than 3 years.

Study Identifies Novel Stress-Inflammation Pathway in AD

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in this process.

Scotland Backs New Immunotherapy in Advanced Cervical Cancer

The Scottish Medicines Consortium has accepted pembrolizumab with chemoradiotherapy for high-risk, locally advanced cervical cancer in Scotland.

Eye Shingles Tied to Cancer Risk in Those With Immune Issues

Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study.

Novo Nordisk Weight-loss Drug Shows Liver Benefits in Mouse Study

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

SLIT Adherence May Lower Rhinitis Severity in Children

Higher adherence to sublingual pollen immunotherapy in children with allergic rhinitis is linked to lower odds of severe rhinitis.

Schistosomiasis: Four Things You May Not Know

From Ancient Egypt to Modern China, how parasitic worms have shaped human health and world history.

C auris Is Now Endemic in Europe. Can It Be Contained?

The fungus, identified only 20 years ago, is endemic in healthcare facilities of five European countries. What can be done to stop its spread?

New Pulmonary Embolism Clinical Categories PCPs Should Know

Dr Nina Lum discusses key takeaways of new PE clinical categories for primary care physicians and providers.

Amgen's Lung Cancer Drug Tarlatamab Wins China Approval

Amgen's lung cancer drug tarlatamab has won ⁠approval from China's National Medical Products Administration.

Recommended News For You

More People Than Previously Believed Have Schizophrenia.

Hereditary cancer has a rare and underreported cause.

One-third of childhood cancer survivors experience significant fear that it could come back, study reveals

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

A promising medication could slow brain tumors in children.

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

How the skin cancer virus outperforms the replication of host cells.

Recommended Articles For You

Understanding Apoplexy: Symptoms, Causes, and Treatment Options  

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease  

Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment 

Unlocking the Mysteries of ICD 10 Code Normocytic Anemia 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

2.

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.

3.

Research identifies nearly 200 potential breast carcinogens in food packaging materials

4.

Low Income, Education Tied to Depression in Older Adults

5.

improvements in the treatment of prostate cancer resistant to chemotherapy.

1.

Case Study: Artificial Intelligence in Early Cancer Detection

2.

Understanding Neutrophilia: Causes, Symptoms, and Treatment Options

3.

Unveiling the Mystery Behind Castleman Disease – Understanding Its Causes and Symptoms 

4.

Understanding Epidural Hematoma: Symptoms, Causes and Treatment 

5.

Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

2.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

5.

Understanding the causes of anemia in adults beyond nutritional deficiencies

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot